Solid numbers, should translate to ~$18m of EBITDA on the midpoint of the sales guidance. Assuming COGS stays around 50% and operating costs more or less double. Pipeline looks really healthy, particularly in China. Would hope to see a few more announcements to that end in the first half of CY20, which would start to underwrite CY21/22.
Ann: Preliminary $50-70m Sales Forecast FY2020, page-6
-
- There are more pages in this discussion • 105 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PET (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.60M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| PET (ASX) Chart |
Day chart unavailable